MILLENNIUM MANAGEMENT LLC - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 120 filers reported holding ANIKA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,703,662
+215.0%
574,539
+339.3%
0.01%
+150.0%
Q2 2023$3,397,560
+1458080.3%
130,776
+1511.1%
0.00%
Q1 2023$233
-93.9%
8,117
-93.8%
0.00%
-100.0%
Q4 2022$3,847
-98.4%
129,961
+1216.9%
0.00%
Q3 2022$235,000
-71.4%
9,869
-73.2%
0.00%
-100.0%
Q2 2022$823,000
-24.3%
36,865
+21.6%
0.00%0.0%
Q4 2021$1,087,000
-18.3%
30,325
-2.9%
0.00%0.0%
Q3 2021$1,330,000
-30.9%
31,244
-29.7%
0.00%0.0%
Q2 2021$1,924,000
-61.7%
44,452
-64.0%
0.00%
-75.0%
Q1 2021$5,030,000
+357.7%
123,326
+407.7%
0.00%
+300.0%
Q4 2020$1,099,000
-35.8%
24,290
-59.0%
0.00%
-75.0%
Q1 2020$1,713,000
-65.6%
59,236
-38.3%
0.00%
-33.3%
Q4 2019$4,978,000
-52.8%
96,014
-50.0%
0.01%
-64.7%
Q3 2019$10,536,000
-10.2%
191,961
-33.5%
0.02%
-5.6%
Q2 2019$11,732,000
+71.2%
288,825
+27.5%
0.02%
+80.0%
Q1 2019$6,851,000
+7.0%
226,557
+18.9%
0.01%0.0%
Q4 2018$6,404,000
+66.6%
190,548
+109.0%
0.01%
+100.0%
Q3 2018$3,845,000
+88.2%
91,161
+42.8%
0.01%
+66.7%
Q2 2018$2,043,000
-5.4%
63,835
+47.0%
0.00%0.0%
Q1 2018$2,159,000
+938.0%
43,415
+1024.4%
0.00%
Q4 2017$208,000
-54.3%
3,861
-50.8%
0.00%
-100.0%
Q3 2017$455,000
-87.9%
7,843
-91.0%
0.00%
-85.7%
Q1 2017$3,775,000
+112.6%
86,892
+139.5%
0.01%
+75.0%
Q4 2016$1,776,000
-80.0%
36,279
-80.5%
0.00%
-73.3%
Q3 2016$8,890,000
+340.5%
185,788
+393.8%
0.02%
+200.0%
Q2 2016$2,018,000
-25.2%
37,622
-37.7%
0.01%
-28.6%
Q1 2016$2,699,000
-57.0%
60,353
-63.3%
0.01%
-46.2%
Q4 2015$6,270,000
-16.6%
164,309
-30.4%
0.01%
-13.3%
Q3 2015$7,515,000
+83.2%
236,089
+90.1%
0.02%
+87.5%
Q2 2015$4,103,000
+99.3%
124,224
+148.4%
0.01%
+100.0%
Q1 2015$2,059,000
-70.3%
50,000
-70.6%
0.00%
-73.3%
Q4 2014$6,930,000
-49.7%
170,096
-54.7%
0.02%
-57.1%
Q3 2014$13,778,000
+142.9%
375,829
+207.0%
0.04%
+118.8%
Q2 2014$5,672,000
+42.0%
122,424
+26.0%
0.02%
+33.3%
Q1 2014$3,993,000
+323.4%
97,152
+293.3%
0.01%
+300.0%
Q4 2013$943,000
+246.7%
24,700
+117.3%
0.00%
+200.0%
Q3 2013$272,000
+23.1%
11,365
-12.4%
0.00%0.0%
Q2 2013$221,00012,9800.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Trigran Investments, Inc. 1,154,183$25,761,0003.00%
CAPITAL MANAGEMENT CORP /VA 275,130$6,141,0001.52%
Kent Lake Capital LLC 98,570$2,200,0001.21%
DIKER MANAGEMENT LLC 21,835$487,0000.60%
Portolan Capital Management 235,972$5,267,0000.53%
Riverwater Partners LLC 12,466$278,0000.28%
Ranger Investment Management 139,661$3,117,0000.24%
Invenomic Capital Management LP 144,287$3,220,0000.23%
CHATHAM CAPITAL GROUP, INC. 23,787$531,0000.12%
Teton Advisors, Inc. 22,000$491,0000.10%
View complete list of ANIKA THERAPEUTICS INC shareholders